We are live on
!
Find out more
JCM
JS Capital Management Portfolio holdings
AUM
$109M
1-Year Est. Return
34.13%
This Fund
S&P 500
This Quarter
Est. Return
+23.51%
1 Year Est. Return
-34.13%
3 Year Est. Return
-16.34%
5 Year Est. Return
-37.7%
10 Year Est. Return
+464.39%
AUM
$1.94B
AUM Growth
+$612M
(+46%)
Cap. Flow
+$440M
Cap. Flow
% of AUM
22.76%
Top 10 Holdings %
Top 10 Hldgs %
82.63%
Holding
243
New
100
Increased
10
Reduced
23
Closed
106
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PLAN
Anaplan, Inc.
PLAN
|
+$17.3M |
| 2 |
JPMorgan Chase
JPM
|
+$13.7M |
| 3 |
PayPal
PYPL
|
+$13.2M |
| 4 |
American Eagle Outfitters
AEO
|
+$12.9M |
| 5 |
Spotify
SPOT
|
+$12.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
10x Genomics
TXG
|
+$47.9M |
| 2 |
PACK.WS
One Madison Corporation Warrants, each whole warrant is exercisable for one Class A Common Stock at
PACK.WS
|
+$26.2M |
| 3 |
O'Reilly Automotive
ORLY
|
+$20.5M |
| 4 |
Meta Platforms (Facebook)
META
|
+$19.9M |
| 5 |
Herbalife
HLF
|
+$19.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 21.94% |
| 2 | Technology | 10.75% |
| 3 | Communication Services | 5.45% |
| 4 | Healthcare | 4.58% |
| 5 | Financials | 2.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Manitowoc
MTW
$497M
| $115K | 0.01% |
+13,637
| New | +$136K |
|
127
Ovid Therapeutics
OVID
$414M
| $107K | 0.01% |
+18,700
| New | +$125K |
|
128
Ocular Therapeutix
OCUL
$1.79B
| $90K | ﹤0.01% |
+11,800
| New | +$97.9K |
|
129
Rayonier Advanced Materials
RYAM
$604M
| $84K | ﹤0.01% |
+26,208
| New | +$84.5K |
|
130
ImmunityBio
IBRX
$7.51B
| $80K | ﹤0.01% |
+11,600
| New | +$116K |
|
131
KALA BIO
KALA
$14.1M
| $80K | ﹤0.01% |
+4
| New | +$91.9K |
|
|
SIEN
132
DELISTED
Sientra, Inc.
SIEN
| $79K | ﹤0.01% |
+2,320
| New | +$87.9K |
|
|
KDMN
133
DELISTED
Kadmon Holdings, Inc.
KDMN
| $74K | ﹤0.01% |
+19,000
| New | +$79.8K |
|
|
RFP
134
DELISTED
Resolute Forest Products Inc.
RFP
| $67K | ﹤0.01% |
+14,978
| New | +$56.1K |
|
135
Alliance Resource Partners
ARLP
$3.34B
| $60K | ﹤0.01% |
+21,800
| New | +$70.2K |
|
136
Titan International
TWI
$466M
| $56K | ﹤0.01% |
+19,400
| New | +$42.7K |
|
137
Akebia Therapeutics
AKBA
$354M
| $37K | ﹤0.01% |
+14,600
| New | +$128K |
|
138
Acadia Pharmaceuticals
ACAD
$4.43B
| – | – |
-17,800
| Closed | -$863K |
|
139
Aecom
ACM
$9.3B
| – | – |
-12,900
| Closed | -$485K |
|
140
Autodesk
ADSK
$49.5B
| – | – |
-1,200
| Closed | -$287K |
|
141
Alector
ALEC
$168M
| – | – |
-9,700
| Closed | -$237K |
|
142
Advanced Micro Devices
AMD
$776B
| – | – |
-14,300
| Closed | -$752K |
|
|
AMED
143
DELISTED
Amedisys
AMED
| – | – |
-8,100
| Closed | -$1.61M |
|
144
Amgen
AMGN
$208B
| – | – |
-1,400
| Closed | -$330K |
|
|
APLT
145
DELISTED
Applied Therapeutics
APLT
| – | – |
-9,700
| Closed | -$351K |
|
146
Arvinas
ARVN
$518M
| – | – |
-7,400
| Closed | -$248K |
|
147
Atmos Energy
ATO
$28.8B
| – | – |
-3,500
| Closed | -$349K |
|
|
DCH
148
Dauch Corp
DCH
$1.34B
| – | – |
-70,300
| Closed | -$534K |
|
149
Axsome Therapeutics
AXSM
$11.2B
| – | – |
-11,900
| Closed | -$979K |
|
150
Bally's
BALY
$682M
| – | – |
-11,900
| Closed | -$265K |
|
Similar funds
SC
WP
CFM
PL
PC
KWM
PCMN
BOTPPF
JS Capital Management's Q3 2020 Portfolio in Review
As of Q3 2020, JS Capital Management held 243 positions worth $1.94B, up 46% from $1.32B the previous quarter. Its ten largest holdings account for 83% of the portfolio.
JS Capital Management deployed $440M of net new capital in Q3 2020, opening 100 new positions and adding to 10 existing holdings. Its largest new stake was Anaplan, Inc.: 335,000 shares worth $21M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, down from 26% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was 10x Genomics, an estimated $47.9M trimmed.
- JS Capital Management's largest Q3 2020 buy was Anaplan, Inc.: 335,000 shares worth $21M.
- JS Capital Management added most to Spotify in Q3 2020, an estimated $12.8M increase.
- JS Capital Management's biggest Q3 2020 reduction was 10x Genomics, cutting an estimated $47.9M.
- JS Capital Management fully exited One Madison Corporation Warrants, each whole warrant is exercisable for one Class A Common Stock at in Q3 2020, selling an estimated $26.2M.
- JS Capital Management's ten largest holdings make up 83% of its $1.94B portfolio in Q3 2020.
- JS Capital Management opened 100 new positions and closed 106 in Q3 2020.
- JS Capital Management's portfolio value rose 46% quarter-over-quarter to $1.94B.
Based on JS Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.